Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6179 USD | -0.45% | -5.38% | -17.13% |
May. 07 | Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy | CI |
Apr. 04 | North American Morning Briefing : Focus Turns to -2- | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.13% | 13.09M | |
+51.48% | 63.85B | |
-2.34% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.21% | 26.52B | |
-21.51% | 18.69B | |
+2.71% | 12.73B | |
+22.29% | 12.11B | |
+27.57% | 12.07B |
- Stock Market
- Equities
- TRAW Stock
- News Traws Pharma, Inc.
- Transcript : Onconova Therapeutics, Inc., Q1 2023 Earnings Call, May 15, 2023